May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Transduced Viral Il–10 Is Exocytosed From Lacrimal Acinar Secretory Vesicles In Response To Carbachol
Author Affiliations & Notes
  • J. Xie
    University of Southern California, Los Angeles, CA
    Department of Pharmaceutical Sciences,
  • D. Stevenson
    University of Southern California, Los Angeles, CA
    Department of Ophthalmology,
  • F.A. Yarber
    University of Southern California, Los Angeles, CA
    Department of Pharmaceutical Sciences,
  • S.F. Hamm–Alvarez
    University of Southern California, Los Angeles, CA
    Department of Pharmaceutical Sciences,
  • M.D. Trousdale
    University of Southern California, Los Angeles, CA
    Department of Ophthalmology,
  • Footnotes
    Commercial Relationships  J. Xie, None; D. Stevenson, None; F.A. Yarber, None; S.F. Hamm–Alvarez, None; M.D. Trousdale, None.
  • Footnotes
    Support  NIH Grants EY012689, EY011386 and EY03040
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1964. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Xie, D. Stevenson, F.A. Yarber, S.F. Hamm–Alvarez, M.D. Trousdale; Transduced Viral Il–10 Is Exocytosed From Lacrimal Acinar Secretory Vesicles In Response To Carbachol . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1964.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine the intracellular trafficking and release pathways of viral IL–10 (vIL–10) from transduced acinar epithelial cells from rabbit lacrimal gland.

Methods: : Rabbit lacrimal gland acinar cells (LGAC) were isolated and maintained for 2 days in a laminin–based primary culture system. Reconstituted acini were transduced with an adenoviral vector carrying the Epstein Barr virus IL–10 gene (AdvIL–10) at a MOI of 5 for 24 hours. The distribution of vIL–10 and that of other compartment markers was assessed by confocal fluorescence microscopy using appropriate primary and fluorescent secondary antibodies. To determine how vIL–10 secretion from LGAC responded to secretagogue stimulation, basal and carbachol (CCH, 100 µM)–stimulated release of vIL–10 and the secretory product, ß–hexosaminidase, were measured from LGAC at time intervals from 0–180 minutes using ELISA and biochemical assays, respectively, and values normalized to pellet protein.

Results: : Confocal fluorescence microscopy revealed that vIL–10 immunoreactivity was detected in a punctate vesicular pattern in resting acini, accumulating primarily in large (0.5–1 µm) subapical vesicles although intracellular labeling could also be detected closer to the basolateral plasma membrane. Preliminary colocalization studies indicated that vIL–10 was partially co–localized with the trans–Golgi network marker, γ–adaptin, and was co–localized to a lesser extent with the Golgi marker, Rab6. vIL–10 was not co–localized with the dynein–associated cofactor, p150Glued. Secretion experiments showed that transduced LGAC secreted vIL–10 at a low but detectable rate in the absence of CCH; CCH stimulation significantly (p≤0.05, n=3) increased the secretory rate at all times measured (0–180 minutes). The curve appeared biphasic, with a robust and linear increase from 0–90 minutes, and tapering off from 90–180 minutes.

Conclusions: : These studies suggest that vIL–10 transgene product is likely to be targeted to mature secretory vesicles localized beneath the apical membrane, which are released in response to CCH stimulation.

Keywords: lacrimal gland • gene transfer/gene therapy • cell membrane/membrane specializations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×